Document Detail


Nutrition and neurodegeneration: epidemiological evidence and challenges for future research.
MedLine Citation:
PMID:  23384081     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The prevention of dementias, such as Alzheimer's disease (AD), is a growing public health concern, due to a lack of effective curative treatment options and a rising global prevalence. Various potential risk or preventive factors have been suggested by epidemiological research, including modifiable lifestyle factors such as diet. Current epidemiological data are in favour of a protective role of certain micronutrients (B vitamins related to homocysteine metabolism, the anti-oxidant vitamins C and E, flavonoids, polyunsatured omega-3 fatty acids, vitamin D) and macronutrients (fish) in the prevention of cognitive decline and dementia/AD. Some factors have been targeted by interventions tested in randomized controlled trials (RCTs), but many of the results are conflicting with observational evidence. Epidemiological analysis of the relations between nutrient consumption and cognitive decline is complex and it is highly unlikely that a single component plays a major role. In addition, since multiple factors across the life course influence brain function in late life, multidomain interventions might be more promising in the prevention of cognitive decline and dementia/AD. Designing such trials remains very challenging for researchers. The main objective of this paper is to review the epidemiologic data linking potential protective factors to cognitive decline or dementia/AD, focusing particularly on the roles of adiposity, caloric restriction, micro (group B vitamins related to homocysteine metabolism, the anti-oxidant vitamins C and E, flavonoids, polyunsatured omega-3 fatty acids, vitamin D) and macronutrients (fish). Limitations of the current data, divergence with results of interventional prevention studies and challenges for future research are discussed.
Authors:
Sophie Gillette-Guyonnet; Marion Secher; Bruno Vellas
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  British journal of clinical pharmacology     Volume:  75     ISSN:  1365-2125     ISO Abbreviation:  Br J Clin Pharmacol     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-02-06     Completed Date:  2013-08-06     Revised Date:  2014-03-06    
Medline Journal Info:
Nlm Unique ID:  7503323     Medline TA:  Br J Clin Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  738-55     Citation Subset:  IM    
Copyright Information:
© 2013 The Authors. British Journal of Clinical Pharmacology © 2013 The British Pharmacological Society.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alzheimer Disease / epidemiology,  prevention & control*
Antioxidants / therapeutic use
Cognition Disorders / epidemiology,  prevention & control*
Diet*
Epidemiologic Studies
Fatty Acids, Omega-3 / therapeutic use*
Humans
Micronutrients / therapeutic use
Nutritional Status
Randomized Controlled Trials as Topic
Risk Factors
Vitamins / therapeutic use*
Chemical
Reg. No./Substance:
0/Antioxidants; 0/Fatty Acids, Omega-3; 0/Micronutrients; 0/Vitamins
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Phytonutrients for bone health during ageing.
Next Document:  Protection from sickle cell retinopathy is associated with elevated HbF levels and hydroxycarbamide ...